STOCK TITAN

Perrigo Increases its Quarterly Dividend

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
dividends
Rhea-AI Summary
Perrigo Company plc (NYSE: PRGO) increases its quarterly dividend by 1% to $0.276 per share, marking the 21st consecutive year of dividend growth.
Positive
  • None.
Negative
  • None.

The dividend increase by Perrigo Company plc represents a continuation of the company's long-term strategy to deliver shareholder value through consistent dividend growth. With this being the 21st consecutive year of dividend increases, it signals to the market a strong commitment to returning value to shareholders. The 1% increase, while modest, may not significantly alter investor returns in the short-term, but it does reinforce the perception of Perrigo as a stable investment, particularly for income-focused shareholders.

From a financial perspective, the dividend policy should be sustainable given the company's cash flow and earnings. Investors should, however, monitor the payout ratio to ensure that dividends are not compromising the company's ability to reinvest in growth opportunities or maintain operational flexibility. Additionally, the market may have already priced in the expectation of a dividend increase, given the company's history, which could mean the immediate stock price reaction may be muted.

The consumer self-care industry is characterized by stable demand and cash flow, which supports consistent dividend payouts. Perrigo's decision to increase its dividend could be seen as an indicator of management's confidence in the company's financial health and the stability of its market position. This move could also be strategically aimed at attracting a certain investor demographic that prioritizes dividend yield in their investment decisions.

It is important to consider the broader market context. If peers in the industry are also raising dividends, Perrigo's increase may be necessary to remain competitive in attracting and retaining investors. Conversely, if Perrigo's increase is out of step with industry trends, it could either suggest a stronger performance relative to its peers or a potential overextension if the industry is facing headwinds that Perrigo is not accounting for.

In an economic environment where interest rates and inflation are fluctuating, a company's decision to increase dividends can be particularly significant. For income investors, dividends can be a hedge against inflation, especially when the increase outpaces inflation rates. In the case of Perrigo, the 1% increase should be evaluated against current inflation trends to determine its real value to shareholders.

Furthermore, the broader economic context can affect consumer spending on self-care products. Economic downturns typically see a rise in consumer focus on value-based purchases, which could benefit companies like Perrigo. However, investors should also be aware of the potential impact of economic recovery, which could shift consumer spending away from self-care products to more discretionary items, potentially affecting Perrigo's revenue and, by extension, its ability to maintain or increase dividends in the future.

DUBLIN, Feb. 26, 2024 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading global provider of Consumer Self-Care Products, announces that its Board of Directors has approved a 1% increase in the Company's quarterly dividend to $0.276 per share, or $1.10 per share on an annual basis, up from $0.273 per share. This marks the 21st consecutive year Perrigo has increased its dividend.

The cash dividend is payable on March 26, 2024, to shareholders of record on March 8, 2024.

About Perrigo 

Perrigo Company plc (NYSE: PRGO) is a leading provider of Consumer Self-Care Products and over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed. Visit Perrigo online at www.perrigo.com

Forward-Looking Statements

This press release includes certain "forward-looking statements" within the meaning of the Private Litigation Securities Reform Act of 1995, as amended. Forward-looking statements relate to future events, such as the timing and amount of future dividend payments, and involve known and unknown risks, uncertainties and other factors—many of which beyond the Company's control—that may cause the actual results, performance or achievements of the Company to be materially different from its current expectations, assumptions, estimates and projections. Interested persons are urged to consult the Company's filings with the United States Securities and Exchange Commission, available at https://investor.perrigo.com/sec-filings, for a discussion of the Company's business and financial condition and certain material trends, risks, uncertainties and other factors relating thereto, including those discussed under "Risk Factors" in the Company's Form 10-K for the year ended December 31, 2022.

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/perrigo-increases-its-quarterly-dividend-302071583.html

SOURCE Perrigo Company plc

Perrigo Company plc's new quarterly dividend amount after the increase is $0.276 per share.

After the increase, the annual dividend per share for Perrigo Company plc is $1.10.

The increased dividend will be payable on March 26, 2024, to shareholders of record on March 8, 2024.
Perrigo Company plc

NYSE:PRGO

PRGO Rankings

PRGO Latest News

PRGO Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
Health Technology, Pharmaceuticals: Other, Manufacturing, Pharmaceutical Preparation Manufacturing
Ireland
Dublin

About PRGO

perrigo company plc, a top five global over-the-counter (otc) consumer goods and pharmaceutical company, offers consumers and customers high quality products at affordable prices. from its beginnings in 1887 as a packager of generic home remedies, perrigo, headquartered in ireland, has grown to become the world's largest manufacturer of otc products and supplier of infant formulas for the store brand market. the company is also a leading provider of branded otc products, generic extended topical prescription products and receives royalties from multiple sclerosis drug tysabri®. perrigo provides “quality affordable healthcare products®” across a wide variety of product categories and geographies primarily in north america, europe, and australia, as well as other key markets including israel and china. visit perrigo online at (http://www.perrigo.com).